Stockreport

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, April 11, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and [Read more]